Comparison between empirical prokinetics, Helicobacter test-and-treat and empirical endoscopy in primary-care patients presenting with dyspepsia: A one-year study

World Journal of Gastroenterology

Volumn 12, Issue 31, 2006, Pages 5010-5016

  Hu, Wayne H C ^a,b   Lam, S K ^a   Lam, Cindy L K ^a   Wong, W M ^a   Lam, K F ^a   Lai, K C ^a   Wong, Y H ^a   Wong, Benjamin C Y ^a   Chan, Annie O O ^a   Chan, C K ^a   Leung, Gabriel M ^a   Hui, W M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Dyspeptic patients; Empirical endoscopy; H pylori test and treat

Indexed keywords

AMOXICILLIN; CISAPRIDE; CLARITHROMYCIN; OMEPRAZOLE; PROKINETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG COST; DRUG RESPONSE; DYSPEPSIA; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART PALPITATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT SATISFACTION; PEPTIC ULCER; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36;

EID: 33748323445     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i31.5010     Document Type: Article

References (36)

1. Hu WH, Wong WM, Lam CL, Lam KF, Hui WM, Lai KC, Xia HX, Lam SK, Wong BC. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther 2002; 16: 2081-2088
2. Bernersen B, Johnsen R, Straume B, Burhol PG, Jenssen TG, Stakkevold PA. Towards a true prevalence of peptic ulcer: the Sorreisa gastrointestinal disorder study. Gut 1990; 31: 989-992
3. Wong BC, Chan CK, Wong KW, Wong WM, Yuen MF, Lai KC, Hu WH, Lau GK, Lai CL, Lam SK. Evaluation of a new referral system for the management of dyspepsia in Hong Kong: role of open-access upper endoscopy. J Gastroenterol Hepatol 2000; 15: 1251-1256
4. Knill-Jones RP. Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol Suppl 1991; 182: 17-24
5. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811-816
6. Rosch W. Cisapride in non-ulcer dyspepsia. Results of a place-bo-controlled trial. Scand J Gastroenterol 1987; 22: 161-164
7. Carvalhinhos A, Fidalgo P, Freire A, Matos L. Cisapride compared with ranitidine in the treatment of functional dyspepsia. Eur J Gastroenterol Hepatol 1995; 7: 411-417
8. Deruyttere M, Lepoutre L, Heylen H, Samain H, Pennoit H. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study. Clin Ther 1987; 10: 44-51
9. Drossman DA, Corazziari E, Talley NJ. Rome II: the functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment: a multinational consensus. 2ed. Mc Lean, Virginia, USA: Degnon Associates, 2000
10. Wong WM, Wong BC, Wong KW, Fung FM, Lai KC, Hu WH, Yuen ST, Leung SY, Lau GK, Lai CL, Chan CK, Go R, Lam SK. (13)C-urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese. Aliment Pharmacol Ther 2000; 14: 1353-1538
11. Lam CL, Gandek B, Ren XS, Chan MS. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol 1998; 51: 1139-1147
12. Hu WH, Lam KF, Wong YH, Lam CL, HUIi WM, Lai KC, Wong BC, Lam SK. The Hong Kong index of dyspepsia: a validated symptom severity questionnaire for patients with dyspepsia. J Gastroenterol Hepatol 2002; 17: 545-551
13. Lai KC, Hui WM, Wong BC, Hu WH, Lam SK. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage. Aliment Pharmacol Ther 2000; 14:1071-1076
14. Wallace MB, Durkalski VL, Vaughan J, Palesch YY, Libby ED, Jowell PS, NickI NJ, Schutz SM, Leung JW, Cotton PB. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut 2001; 49: 29-34
15. Hu WH, Talley NJ. Functional (non-ulcer) dyspepsia: unexplained but not unmanageable. Med J Aust 1998; 168: 507-512
16. Wong BC, Chan CK, Wong KW, Wong WM, Yuen MF, Lai KC, Hu WH, Lau GK, Lai CL, Lam SK. Evaluation of a new referral system for the management of dyspepsia in Hong Kong: role of open-access upper endoscopy. J Gastroenterol Hepatol 2000; 15: 1251-1256
17. Dobrilla G, Comberlato M, Steele A, Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 1989; 11: 169-177
18. Talley NJ, McNeil D, Hayden A, Piper DW. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. Gastroenterology 1986; 91:149-156
19. Fennerty MB. Use of antisecretory agents as a trial of therapy Gut 2002; 50 Suppl 4: iv63-iv66
20. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H. Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998; 12: 1055-1065
21. Bytzer P. H-2 receptor antagonists and prokinetics in dyspepsia: a critical review. Gut 2002; 50 Suppl 4: iv58-iv62
22. Finney JS, Kinnersley N, Hughes M, O'Bryan-Tear CG, Lothian J. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998; 26: 312-320
23. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339: 1869-1874
24. Blum AL, Talley NJ, O'Morain C, van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Stemevald E, Junghard O. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 1998; 339: 1875-1881
25. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 1998; 114: 579-581
26. Talley NJ, Lam SK, Goh KL, Fock KM. Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region: First Asian Pacific Working Party on Functional Dyspepsia. J Gastroenterol Hepatol 1998; 13: 335-353
27. Lassen AT, Pedersen FM, Bytzer P, Schaffalitzky de Muckadell OB. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randonmised trial. Lancet 2000; 356: 455-460
28. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996; 110: 72-83
29. Ofman JJ, Etchason J, Fullerton S, Kahn KL, Soll AH. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and econonomic consequences. Ann Intern Med 1997; 126: 280-291
30. Spiegel BM, Vakil NB, Ofman JJ. Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology 2002; 122:1270-1285
31. Delaney BC, Wilson S, Roalfe A, Roberts L, Redman V, Wearn A, Hobbs FD. Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. BMJ 2001; 322: 898-901
32. Wong WM, Wong BC, Hung WK, Yee YK, Yip AW, Szeto ML, Fung FM, Tong TS, Lai KC, Hu WH, Yuen MF, Lam SK. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut 2002; 51: 502-506
33. Howell S, Talley NJ. Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice? Eur J Gastroenterol Hepatol 1999; 11: 881-886
34. Conry BG, McLean AM, Farthing MJ. Diagnostic and therapeutic efficacy of barium meal examination: a prospective evaluation in general practice. BMJ 1989; 299: 1443-1445
35. Jones R, Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Pract 1992; 46: 95-97
36. Breslin NP, Thomson AB, Bailey RJ, Blustein PK, Meddings J, Lalor E, VanRosendaal GM, Verhoef MJ, Sutherland LR. Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut 2000; 46: 93-97